Clinical Trial Update: INSELMA - a Randomised Controlled Trial [NA]

View source ↗

Summary

INSELMA is a randomized controlled trial that is currently recruiting for rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Snippet

Sponsor: The Danish Center for Expertise in Rheumatology | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | NA | Status: RECRUITING